Abatacept

51 interactions 44 explained in plain English 71 cited references
Also sold as: Orencia
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 16, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Adalimumab Injection Brodalumab Injection Golimumab Injection Adalimumab Alefacept Anifrolumab-Fnia
33 Major 18 Moderate
All (51) Major (33) Moderate (18)

Major

Abatacept Adalimumab Injection Abrilada Explained An increased risk of infection Details Abatacept Anakinra Kineret Explained An increased risk of infection Details Abatacept Anifrolumab-Fnia Injection Saphnelo Explained Additive effects due to duplication of therapy Details Abatacept Adalimumab Explained An increased risk of infection Details Abatacept Alefacept Explained An increased risk of infection Details Abatacept Anifrolumab-Fnia Saphnelo Explained Additive effects due to duplication of therapy Details Abatacept Baricitinib Olumiant An increased risk of infection Details Abatacept Brodalumab Explained An increased risk of infection Details Abatacept Certolizumab Pegol Explained An increased risk of infection Details Abatacept Etanercept Explained An increased risk of infection Details Abatacept Fedratinib Inrebic Explained An increased risk of infection Details Abatacept Golimumab Explained An increased risk of infection Details Abatacept Guselkumab Explained An increased risk of infection Details Abatacept Infliximab Avsola Explained An increased risk of infection Details Abatacept Ixekizumab Explained An increased risk of infection Details Abatacept Natalizumab Explained An increased risk of infection Details Abatacept Risankizumab Explained An increased risk of infection Details Abatacept Rituximab Explained An increased risk of infection Details Abatacept Ruxolitinib Jakafi Explained An increased risk of infection Details Abatacept Sarilumab Explained An increased risk of infection Details Abatacept Secukinumab Explained An increased risk of infection Details Abatacept Tildrakizumab Explained An increased risk of infection Details Abatacept Tocilizumab Actemra Explained An increased risk of infection Details Abatacept Tofacitinib Xeljanz Explained An increased risk of infection Details Abatacept Upadacitinib Rinvoq Explained An increased risk of infection Details Abatacept Ustekinumab Explained An increased risk of infection Details Abatacept Vedolizumab Explained An increased risk of infection Details Abatacept Brodalumab Injection Siliq An increased risk of infection Details Abatacept Certolizumab Injection Cimzia An increased risk of infection Details Abatacept Golimumab Injection Simponi An increased risk of infection Details Abatacept Guselkumab Injection Tremfya An increased risk of infection Details Abatacept Ixekizumab Injection Taltz An increased risk of infection Details Abatacept Natalizumab Injection Tyruko An increased risk of infection Details

Moderate

Abatacept Adenovirus Vaccine Type 4, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details Abatacept Adenovirus Vaccine Type 7, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details Abatacept Bacillus Of Calmette And Guerin Vaccine, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details Abatacept Dengue Tetravalent Vaccine, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details Abatacept Influenza Virus Vaccine, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details Abatacept Measles Virus Vaccine, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details Abatacept Mumps Virus Vaccine, Live Explained Secondary transmission of infection by the live vaccine; reduced effectiveness of immunization Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.